Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
S. pneumoniae community-acquired pneumonia (SP-CAP): relationship between mortality and antibiotic susceptibility and risk factors for drug resistanceSource: Eur Respir J 2001; 18: Suppl. 33, 503s Year: 2001
Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Streptococcus pneumoniae resistance pattern and its clinical implicationsSource: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia Source: Eur Respir J 2006; 27: 1010-1019 Year: 2006
The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized? Source: Annual Congress 2009 - Pulmonary infections Year: 2009
Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010
Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001
Clinical aspects of chlamydia pneumoniae pneumonia in adults Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Differences in prognostic factors and outcome in community-acquired pneumonias (CAP) caused by viral pathogens (VP) or streptococcus pneumoniae (SP) Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001
Antibiotic usage analysis of the community-acquired pneumonia at young patients from different social groups Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003
Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006
Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseasesSource: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005
Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in community-acquired pneumonia Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015